Latest Breaking News On - Society international research congress - Page 1 : comparemela.com

Dyne Therapeutics Presents New Preclinical Data for its Facioscapulohumeral Muscular Dystrophy Program During the FSHD Society International Research Congress

Dyne Therapeutics Presents New Preclinical Data for its Facioscapulohumeral Muscular Dystrophy Program During the FSHD Society International Research Congress
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesStacy nartkerAmy reillyOxana beskrovnayaExchange commissionSociety international research congressDyne therapeutics incFunctional benefitInternational research congressScientific publicationsFacioscapulohumeral muscular dystrophyPrivate securities litigation reform act

Dyne Therapeutics Presents New Preclinical Data for its

Dyne Therapeutics Presents New Preclinical Data for its
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

United statesAmy reillyStacy nartkerOxana beskrovnayaExchange commissionSociety international research congressDyne therapeutics incFunctional benefitInternational research congressScientific publicationsFacioscapulohumeral muscular dystrophyPrivate securities litigation reform act

Avidity Up 33% on Rare Muscle Disease Study Results - Arcutis Biotherapeutics (NASDAQ:ARQT), Heron Therapeutics (NASDAQ:HRTX)

Avidity Biosciences (NASDAQ: RNA) announced encouraging initial data from the phase I/II FORTITUDE study evaluating two doses of delpacibart braxlosiran (del-brax, or formerly AOC 1020) in facioscapulohumeral muscular dystrophy (FSHD), a rare genetic disease of the muscles.

United statesMarinus pharmaceuticalsArcutis biotherapeuticHeron therapeuticsArcutis biotherapeuticsEarnings of marinus pharmaceuticalsSociety international research congressAvidity biosciences incAvidity bioscienceInternational research congressAvidity biosciencesZacks rankMarinus pharmaceuticalHeron therapeutic

Dyne Therapeutics Presents New Preclinical Data for its Facioscapulohumeral Muscular Dystrophy Program During the FSHD Society International Research Congress

Dyne Therapeutics Presents New Preclinical Data for its Facioscapulohumeral Muscular Dystrophy Program During the FSHD Society International Research Congress
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesAmy reillyOxana beskrovnayaStacy nartkerFacioscapulohumeral muscular dystrophy program duringExchange commissionSociety international research congressDyne therapeutics incTherapeutics presents new preclinical dataInternational researchFunctional benefitInternational research congressScientific publicationsFacioscapulohumeral muscular dystrophyPrivate securities litigation reform act

Avidity Biosciences to Present Preliminary Data from Phase 1/2 FORTITUDE™ Trial of AOC 1020 in People Living with Facioscapulohumeral Muscular Dystrophy at 31st Annual FSHD Society International Research Congress

Avidity Biosciences to Present Preliminary Data from Phase 1/2 FORTITUDE™ Trial of AOC 1020 in People Living with Facioscapulohumeral Muscular Dystrophy at 31st Annual FSHD Society International Research Congress
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoGeoffrey grandeJeffreym statlandNavjot raiSociety international research congressAvidity biosciences incPrnewswire avidity biosciences incUniversity of kansas medical centerKansas medical centerAntibody oligonucleotide conjugatesInternational research congressRandomized phaseClinical trial participationClinical trial siteOligonucleotide conjugates